The Research Institute at Nationwide Children's Hospital
Licenses Acumenta Literature Lab™
Boston, MA – December 3, 2009: The Biomedical Genomics Core of The Research
Institute at Nationwide Children's Hospital has licensed Acumenta Corporation's
Literature Lab™ to accelerate the understanding of biology associated with
experimentally derived gene lists.
A novel literature mining application, Literature Lab™ performs a statistical analysis on
the scientific literature as it relates to experimentally derived gene sets. It uniquely
solves two major challenges shared by virtually all investigators engaged in microarray
analysis and other genomic experimentation:
- Gaining a thorough understanding of the biological implications of their gene lists.
- Keeping up to date with scientific literature, and using it to accelerate their research.
“We were very impressed by the capabilities and user friendly interface of Literature
Lab” said Peter White, Ph.D. Assistant Professor and Director of the Biomedical
Genomics Core at Nationwide Children's Hospital (genomics.nchresearch.org). “Most
importantly for us was the ease with which we could incorporate it into our analysis
pipeline, and rapidly share the results with the investigators we support. Going from a
gene list to interpreting the biology contained in that list is a difficult step, and Literature
Lab” is now one of our key tools we use to achieve this.”
“Literature Lab™ breaks new ground for genomic analysis tools with its high level of
automation and simplified turnkey operation.” said Stephen C. Taylor, Acumenta's CEO.
“Core facilities are very busy places, and the ability of Literature Lab™ to integrate into
existing pipelines and automatically generate new analyses is a valuable asset.”
“By rigorously identifying key biological relationships and delivering concise, quickly
reviewed results, investigators get to think first and foremost about biology, and not
about how to use the analysis tool.” said Paul Martinez, Acumenta's Vice President of
Sales and Marketing. “All the detail and supporting data is instantly available when the
need for it arises.”
Literature Lab™ analyses are provided by Acumenta as a service or as a turn-key
software application.
Acumenta Corporation, based in Boston, Massachusetts, is a software and information
company serving biotechnology and pharmaceutical firms and non-profit research
organizations. Acumenta builds applications that automate information gathering,
analysis and management tasks on public Web-based and proprietary external and
internal databases. Acumenta's software products and its curated Thesaurus of Gene
and Protein Nomenclature improve both the efficiency and quality of research in the life
sciences R&D function.
Contact: Paul Martinez
Title: Vice President Sales & Marketing
Phone: 617-379-0691
Email: pmartinez@Acumenta.com
URL: www.Acumenta.com |
